IL-23 P19/IL-23A hFc Chimera, Human
IL-23 P19/IL-23A HFc Chimera, Human

IL-23 P19/IL-23A hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

IL-23 P19/IL-23A hFc Chimera, Human

IL-23 is a heterodimeric cytokine composed of a unique p19 subunit and a common p40 subunit is shared with IL-12. IL-23 promotes the inflammatory response by inducing the expansion of CD4(+) cells producing IL-17.
Z05483
¥69,021.00

Ask us a question
Product Introduction
Species Human
Protein Construction
IL-23 P19/IL-23A (Arg20-Pro189)
Accession # Q9NPF7		 hFc
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 45.43 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • IL-23 P19/IL-23A HFc Chimera, Human
    • IL-23 P19/IL-23A HFc Chimera, Human

    IL-23 P19/IL-23A hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background IL-23 is a heterodimeric cytokine composed of a unique p19 subunit and a common p40 subunit is shared with IL-12. IL-23 promotes the inflammatory response by inducing the expansion of CD4(+) cells producing IL-17.
Synonyms IL-23 P19; IL-23A; IL-23-A; IL-23p19; IL23p19; SGRF

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.